Investing.com - Bicycle Therapeutics (NASDAQ:BCYC) reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Bicycle Therapeutics announced earnings per share of $-0.67 on revenue of $1.57M. Analysts polled by Investing.com anticipated EPS of $-0.48 on revenue of $2.36M.
Bicycle Therapeutics shares are up 66.38% from the beginning of the year, still down 21.94% from its 52 week high of $20.10 set on July 14. They are outperforming the Nasdaq which is up 22.53% from the start of the year.
Bicycle Therapeutics shares lost 3.86% in intra-day trade following the report.
Bicycle Therapeutics follows other major Healthcare sector earnings this month
Bicycle Therapeutics's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar